An interactive web-tool for molecular analyses links naturally occurring mutation data with three-dimensional structures of the rhodopsin-like glycoprotein hormone receptors

Human Mutation

Volumn 31, Issue 6, 2010, Pages

  Kleinau, Gunnar ^a,b   Kreuchwig, Annika ^a   Worth, Catherine L ^a   Krause, Gerd ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Database; FSHR; Glycoprotein hormone receptors; LHCGR; Naturally occurring mutations; TSHR

Indexed keywords

AMINO ACID; GLYCOPROTEIN HORMONE RECEPTOR; HORMONE RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; GLYCOPROTEIN; RHODOPSIN;

CLASSIFICATION; COMPUTER INTERFACE; DATA ANALYSIS; DATA BASE; GENE MUTATION; INTERNET; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; GENETICS; HUMAN; INFORMATION RETRIEVAL; MUTATION; PROCEDURES; PROTEIN CONFORMATION; PROTEIN DATABASE;

COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; GLYCOPROTEINS; HUMANS; INFORMATION STORAGE AND RETRIEVAL; INTERNET; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE; RHODOPSIN; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 77952701945     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21265     Document Type: Review

References (34)

1. Alberti L, Proverbio MC, Costagliola S, Weber G, Beck-Peccoz P, Chiumello G, Persani L. 2001. A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol 145:249-254. (Pubitemid 32825657)
2. Ascoli M, Fanelli F, Segaloff DL. 2002. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23:141-174.
3. Corvilain B, Van Sande J, Dumont JE, Vassart G. 2001. Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55:143-158.
4. Davies TF, Ando T, Lin RY, Tomer Y, Latif R. 2005. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest 115:1972-1983.
5. Esapa CT, Duprez L, Ludgate M, Mustafa MS, Kendall-Taylor P, Vassart G, Harris PE. 1999. A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis. Thyroid 9:1005-1010. (Pubitemid 29521985)
6. Fan QR, Hendrickson WA. 2005. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433:269-277.
7. Flower DR. 1999. Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1422:207-234.
8. Fuhrer D, Lachmund P, Nebel IT, Paschke R. 2003. The thyrotropin receptor mutation database: update 2003. Thyroid 13:1123-1126. (Pubitemid 38032396)
9. Gozu HI, Bircan R, Krohn K, Muller S, Vural S, Gezen C, Sargin H, Yavuzer D, Sargin M, Cirakoglu B, Paschke R. 2006. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 155:535-545.
10. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA, Paschke R. 1997. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab 82:4229-4233.
11. Horn F, Weare J, Beukers MW, Horsch S, Bairoch A, Chen W, Edvardsen O, Campagne F, Vriend G. 1998. GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res 26:275-279.
12. Karges B, Krause G, Homoki J, Debatin KM, de Roux N, Karges W. 2005. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. J Endocrinol 186:377-385.
13. Kazius J, Wurdinger K, van Iterson M, Kok J, Back T, Ijzerman AP. 2008. GPCR NaVa database: natural variants in human G protein-coupled receptors. Hum Mutat 29:39-44.
14. Kleinau G, Brehm M, Wiedemann U, Labudde D, Leser U, Krause G. 2007a. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Mol Endocrinol 21:574-580.
15. Kleinau G, Claus M, Jaeschke H, Mueller S, Neumann S, Paschke R, Krause G. 2007b. Contacts between extracellular loop two and transmembrane helix six determine basal activity of the thyroid-stimulating hormone receptor. J Biol Chem 282:518-525.
16. Kleinau G, Jaeschke H, Mueller S, Worth CL, Paschke R, Krause G. 2008. Molecular and structural effects of inverse agonistic mutations on signaling of the thyrotropin receptor-a basally active GPCR. Cell Mol Life Sci 65:3664-3676.
17. Kleinau G, Krause G. 2009. Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr Rev 30:133-151.
18. Kosugi S, Hai N, Okamoto H, Sugawa H, Mori T. 2000. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. Eur J Endocrinol 143:471-477.
19. Kristiansen K. 2004. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-proteincoupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21-80.
20. Lachmund P, Nebel IT, Fuhrer D, Paschke R. 2004. The pedigree tool: web-based visualization of a family tree. Hum Mutat 23:103-105.
21. Overington JP, Al Lazikani B, Hopkins AL. 2006. How many drug targets are there? Nat Rev Drug Discov 5:993-996.
22. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. 1998. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716. (Pubitemid 128506520)
23. Rapoport B, McLachlan SM. 2007. The thyrotropin receptor in Graves' disease. Thyroid 17:911-922.
24. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M, Richards T, Powell M, Miguel RN, Blundell TL, Furmaniak J, Smith BR. 2007. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17:395-410. (Pubitemid 46878842)
25. Schoneberg T, Schulz A, Biebermann H, Hermsdorf T, Rompler H, Sangkuhl K. 2004. Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther 104:173-206.
26. Schoneberg T, Schulz A, Gudermann T. 2002. The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev Physiol Biochem Pharmacol 144:143-227.
27. Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE. 2006. Molecular mechanism of 7TM receptor activation - a global toggle switch model. Annu Rev Pharmacol Toxicol 46:481-519.
28. Simoni M, Gromoll J, Nieschlag E. 1997. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739-773.
29. Smit MJ, Vischer HF, Bakker RA, Jongejan A, Timmerman H, Pardo L, Leurs R. 2007. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 47:53-87.
30. Szkudlinski MW, Fremont V, Ronin C, Weintraub BD. 2002. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82:473-502.
31. Tao YX. 2006. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol Ther 111:949-973.
32. Tao YX. 2008. Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics. Pharmacol Ther 120:129-148.
33. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D, Paschke R. 2001. Detection of thyroidstimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684-691.
34. Van Durme J, Horn F, Costagliola S, Vriend G, Vassart G. 2006. GRIS: glycoprotein-hormone receptor information system. Mol Endocrinol 20:2247-2255.